Top Income Stocks To Invest In Right Now

It�� not rocket science. Neither does it entail you living like a monk. Just follow these three tips and you are building a solid foundation.

Avoid credit card debt:

It�� time you stopped your intense love affair with your credit card or else you will rapidly be sucked into a black hole called the debt trap. It starts off as a convenience, more of a stop-gap arrangement. You pay just the bare minimum amount and walk scot free. But as you well know, or will soon learn, there is no free lunch.

Remember this. When you use your card, you pay for an item with money that is not yours. So basically you enjoy life on borrowed money. This instant gratification can put you on a slippery slope. If you have started revolving credit, which means that you could not afford to pay your monthly bill, then the only way out of this ditch is to stop using your card till your debt is cleared.

Let�� say you are revolving your debt at a rate of 2.75%/month. This works out to an obscene 33% pa which will rapidly eat into your disposable income and dramatically hinder your savings potential. And, it will not be just the debt that you are servicing. Every single purchase you make on that card will result in the interest rate being levied.

Best Managed Healthcare Companies To Buy For 2015: Medbox Inc (MDBX)

Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs. The system also allows these clinics to demonstrate that the user visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. The Company has national and international presence with offices in Los Angeles, New York, Toronto, London and Tokyo.

Medbox, through its subsidiaries, offers consulting services to the alternative medicine industry, as well as to the mini self-storage market. The Company provides consulting services primarily to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning the availability of alternative medicines, as well as existing jurisdictions, nationwide.

Advisors' Opinion:

• [By Peter Graham]

  What�� the Catch With Endocan Corp? According to various disclosures, a transaction or transactions of $10k has or will occur to mention Endocan Corp in various investment newsletters. However, Endocan Corp has actually been quiet since early February when the company issued a press release to say that they were ��elighted��that the US Congress and President Obama appear on the verge of approving the first key law to legalize hemp cultivation and advanced research on a federal level (Note: On January 29, 2014, the US House of Representatives approved the "farm bill" that contains a provision for certain cultivation of industrial hemp for research in a number of US states). Endocan Corp also issued ��hareholder guidance��concerning an multi-year, strategic growth agreement with Medicine Dispensing Systems, a wholly owned subsidiary of Medbox Inc (OTCMKTS: MDBX), that was announced on August 20, 2013. Under that agreement, Endocan Corp will be bringing proprietary cannabinoid-based products and formulations to market in state-approved regulatory environments with dispensaries to be branded by the company while using the advanced, patented 'Medbox' dispensing technology. However, the latest financials for Endocan Corp date from the end of March 2013 ��meaning the company has some catching up to do.

• [By Ben Levisohn]

  But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).

• [By Bryan Murphy]

  When Tranzbyte Corp. (OTCMKTS:ERBB) and Medbox Inc. (OTCMKTS:MDBX) both announced they would be unveiling vending machines to dispense medical marijuana and/or recreational marijuana, fans and supporters of hemp/pot applauded the ease of access, but even some of the most die-hard supporters saw potential problems. Although the machines made by MDBX and ERBB would only dispense marijuana if a strong verification procedure had been successfully performed, there was just something a little un-nerving about an un-manned metal box that - given the right hacking capabilities - could be fooled into giving marijuana to someone who shouldn't have it. Or barring that, the machines (which are admittedly solid and stout) could still be vandalized, broken, or even outright stolen if left unprotected. Those are long shots, granted, but thieves know few bounds.

• [By James E. Brumley]

  Wow. That didn't take long. It was only two days ago that marijuana stocks like Growlife Inc. (OTCBB:PHOT), Medical Marijuana Inc. (OTCMKTS:MJNA), Cannabis Science Inc. (OTCMKTS:CBIS), Medbox Inc. (OTCMKTS:MDBX), and Hemp, Inc. (OTCMKTS:HEMP) were all the rage, flying high on the heels of a new year... a new year in which marijuana was legalized (for one reason or another) in two more states. HEMP was up as much as 700% in less than three weeks at one point. MDBX gained 300% at the beginning of the year, when recreational marijuana began to be legally sold in Colorado. CBIS jumped 400% off of its December low. MJNA nearly doubled on the advent of new marijuana venues. PHOT soared more than 130% since the end of last year on the legalization of marijuana. It was, truthfully, some of the fastest big money that traders have ever made in the market.

Top Income Stocks To Invest In Right Now: Societe Libanaise des Ciments Blancs SAL (CBN)

Societe Libanaise des Ciments Blancs SAL is a Lebanon-based joint stock company that operates in the construction materials industry sector. The Company is engaged in the production and sale of white cement. The Company is a 65.99% owned by Holcim (Liban) SAL. Advisors' Opinion:

• [By CanadianValue]

  Nigeria�� reformed banking system has provided many foreigners with an attractive means to invest in the fast-growing domestic economy. The banking industry is important, not only because of the rise of microfinance, but because of the move by banks into consumer banking. Until recently, banks were mainly financing large businesses or the government through bond purchases. Following a banking crisis in 2008, the Central Bank of Nigeria (CBN) conducted an audit of the commercial banking sector. All banks that failed the audit had their CEOs replaced. The state-owned Asset Management Corporation (AMCON) was created to purchase non-performing loans and recapitalize the unhealthy banks. A recent review of the country�� banks by the IMF showed a dramatic increase in profits for the industry in 2012, while the capital adequacy ratio was above the minimum requirement of 10% and non-performing loans were below the mandated threshold of 5%5.

Top Income Stocks To Invest In Right Now: Conn's Inc.(CONN)

Conn?s, Inc. operates as a specialty retailer of home appliances, consumer electronics, home office equipment, lawn and garden products, mattresses, and furniture in the United States. Its home appliances products include refrigerators, freezers, washers, dryers, dishwashers, ranges, and room air conditioners; consumer electronics products consist of LED, LCD, plasma, DLP and 3-D televisions, camcorders, digital cameras, Blu-ray and DVD players, video game equipment, portable audio, MP3 players, GPS devices, and home theater products; and furniture and mattresses include living room, bedroom, and dining room furniture. The company's products also comprise lawn and garden equipment, which includes lawn mowers, lawn tractors, and handheld equipment; and home office equipment, including computers, notebooks, and computer accessories. It also offers repair service agreements and customer credit programs, including installment and revolving credit account programs, and various credit insurance products. In addition, the company sells its products online. As of January 20, 2012, it operated 70 retail locations in Texas, Louisiana, and Oklahoma. The company was founded in 1890 and is headquartered in Beaumont, Texas.

Advisors' Opinion:

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  Conn's Inc.(CONN) said its fiscal fourth-quarter earnings rose 57% behind sales growth in all the specialty retailer’s categories. The results fell short of expectations, but the specialty retailer said credit portfolio performance has improved since the quarter ended with delinquency declining. Shares rose 8.9% to $37.58 premarket.

• [By Lisa Levin]

  Electronics Stores: This industry moved up 1.16% by 10:15 am. The top performer in this industry was Conns (NASDAQ: CONN), which gained 1.3%. Conns' PEG ratio is 0.87.

Top Income Stocks To Invest In Right Now: STARWOOD PROPERTY TRUST INC.(STWD)

Starwood Property Trust, Inc., a real estate investment trust, primarily focuses on originating, investing in, financing, and managing commercial mortgage loans and other commercial real estate debt investments, commercial mortgage-backed securities, and other commercial real estate-related debt investments. It also focuses to invest in commercial properties subject to net leases, residential mortgage loans, and residential mortgage-backed securities. SPT Management, LLC serves as the manager of Starwood Property Trust, Inc. The company qualifies as a real estate investment trust for federal income tax purposes and would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. Starwood Property Trust was founded in 2009 and is headquartered in Greenwich, Connecticut.

Advisors' Opinion:

• [By Amanda Alix]

  Other companies are currently mulling single-family REIT IPOs, too. Colony recently announced�that it plans to spin off its Colony American Homes, which owns over 9,500 homes with average monthly rents of $1,277. Barry Sternlicht, CEO of commercial mortgage investment REIT Starwood Property Trust (NYSE: STWD  ) has also said that he is seriously considering�spinning off his company's real estate holdings into a single-family REIT within the next few months.

• [By Doug Fabian]

  This fund is pegged to the FTSE NAREIT All Mortgage Capped Index, a benchmark measure that includes top names in the space such as Annaly Capital (NLY), American Capital Agency Corp. (AGNC), Starwood Property Trust (STWD) and Two Harbors Investment Corp. (TWO).

Top Income Stocks To Invest In Right Now: Furiex Pharmaceuticals Inc (FURX)

Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�� product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.

Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). Alogliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).

Fluoroquinolone drug candidate is a Phase II-ready novel fluoroquinolone antibiotic that is being developed by the Company for the treatment of complicated skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections. This antibiotic has a spectrum of activity and is able to treat methicillin-resistant staphylococcus aureus (MRSA) infections. The Company is developing both oral and intravenous (IV) formulations. The Company is developing Mu Delta for treatment of diarrheal predominant irritable bowel syndrome (d-IBS). The Company is conducting a Phase II study on an oral formulation of Mu Delta.

The Company is developing PPD 10558 for the treatment of dyslipidemia. PPD 10558 has shown muscle safety in preclinical studies by minimizing the delivery of the drug to the muscle. The Company has filed an inve! stigational new drug (IND) application with the United States Food and Drug Association and completed five clinical studies.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap drug development collaboration company Furiex Pharmaceuticals Inc (NASDAQ: FURX) surged 129.91% after announcing that its experimental drug had alleviated diarrhea and abdominal pain caused by irritable bowel syndrome in two studies, meaning its worth taking a closer look at the stock because that�� a condition that effects millions of people (with no other effective drug to treat it) plus take a look at the�performance of biotech benchmarks iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

• [By Jake L'Ecuyer]

  Top Headline
  Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014.

• [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Forest Laboratories Inc.(FRX) agreed to acquire Furiex Pharmaceuticals(FURX) in a deal worth up to $1.33 billion that expands Forest Labs’ presence in gastroenterology. Furiex surged 28% to $102.21 premarket.

Top Income Stocks To Invest In Right Now: Fonar Corporation(FONR)

FONAR Corporation engages in the research, development, production, marketing, and service of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases. It provides Upright Multi-positional MRI scanners, which allow patients to be scanned in a weight-bearing condition, such as standing, sitting, or bending in any position that causes symptoms; and FONAR 360 MRI scanner, a diagnostic scanner. The company, through its wholly owned subsidiary, Health Management Corporation of America, also offers management services to imaging facilities, including development, administration, and leasing of office space, facilities, and medical equipment; provision of supplies; staffing, training, and supervision of non-medical personnel; legal services; accounting, billing, and collection; and the development and implementation of practice growth and marketing strategies. It serves private diagnostic imaging centers and hospitals. As of June 30, 2011, the c ompany managed 10 diagnostic imaging facilities located in the states of New York and Florida. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  NASDAQ OMX Group (Nasdaq: NDAQ) and Borsa Istanbul A.S. have today concluded a wide-ranging agreement, which includes the delivery of market-leading technologies and advisory services to Borsa Istanbul, and NASDAQ OMX taking an equity stake in Borsa Istanbul. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Bolt MRI Technologies LLC subsidiary has entered into an agreement with Fonar Corporation (NASDAQ: FONR). To read the full news, click here. Douglas Emmett, (NYSE: DEI) announced that William Kamer will be retiring from full time service as its Chief Investment Officer effective January 31, 2014. Mr. Kamer will continue to be employed by Douglas Emmett as a Senior Advisor. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary has entered into a settlement and patent license agreement with Alcatel-Lucent USA (NYSE: ALU). To read the full news, click here.

  Posted-In: Benchmark US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets